Volume 65, Issue 1, Pages (January 2014)

Slides:

Advertisements

Similar presentations

Volume 61, Issue 5, Pages (May 2012)

Advertisements

The PSA Era is not Over for Prostate Cancer

Volume 71, Issue 6, Pages (June 2017)

Volume 64, Issue 6, Pages (December 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 44, Issue 6, Pages (December 2003)

Volume 52, Issue 3, Pages (September 2007)

Volume 66, Issue 1, Pages (July 2014)

Volume 56, Issue 6, Pages (December 2009)

Volume 52, Issue 1, Pages (July 2007)

Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging:

Volume 74, Issue 2, Pages (August 2018)

Volume 63, Issue 1, Pages (January 2013)

Volume 67, Issue 3, Pages (March 2015)

Volume 53, Issue 5, Pages (May 2008)

Volume 57, Issue 6, Pages (June 2010)

Volume 64, Issue 6, Pages (December 2013)

Dynamic Contrast-Enhanced MRI for Preoperative Identification of Localised Prostate Cancer Arnauld Villers, Philippe Puech, Xavier Leroy, Jacques Biserte,

Prostate Cancer Epidemic in Sight?

Volume 65, Issue 6, Pages (June 2014)

Volume 72, Issue 3, Pages (September 2017)

Volume 58, Issue 1, Pages (July 2010)

Volume 66, Issue 1, Pages (July 2014)

Volume 63, Issue 4, Pages e53-e56 (April 2013)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 54, Issue 4, Pages (October 2008)

Pitfalls of Pathologic Staging in Prostate Cancer

Volume 52, Issue 3, Pages (September 2007)

Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI- RADS v2) scoring system in diagnosis of peripheral zone prostate cancer

Prostate Cancer Detection: A View of the Future

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 62, Issue 6, Pages (December 2012)

Volume 69, Issue 6, Pages (June 2016)

Volume 56, Issue 2, Pages (August 2009)

Volume 70, Issue 5, Pages (November 2016)

Volume 67, Issue 4, Pages (April 2015)

Volume 71, Issue 6, Pages (June 2017)

The standards of an ultrasound examination of the prostate gland

Volume 73, Issue 4, Pages (April 2018)

Volume 59, Issue 6, Pages (June 2011)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 72, Issue 5, Pages (November 2017)

Volume 61, Issue 5, Pages (May 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 68, Issue 6, Pages (December 2015)

Leonard S. Marks, Jiaoti Huang European Urology

Volume 54, Issue 3, Pages (September 2008)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 65, Issue 6, Pages (June 2014)

Tillmann Loch, Pat Fox Fulgham European Urology

Volume 68, Issue 4, Pages (October 2015)

Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer Valeria.

Volume 58, Issue 1, Pages (July 2010)

Volume 50, Issue 5, Pages (November 2006)

Volume 53, Issue 1, Pages (January 2008)

Jean J.M.C.H. de la Rosette, Vladimir Mouraviev, Thomas J. Polascik

Volume 71, Issue 3, Pages (March 2017)

Volume 65, Issue 3, Pages (March 2014)

European Urology is “Your” Journal

Volume 49, Issue 6, Pages (June 2006)

Volume 66, Issue 1, Pages (July 2014)

Luis Martínez-Piñeiro European Urology

Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.

Volume 69, Issue 1, Pages (January 2016)

The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review Fritz Schröder,

Computer Simulation of Prostate Biopsies

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Volume 51, Issue 5, Pages (May 2007)

Introduction European Urology Supplements

Presentation transcript:

Volume 65, Issue 1, Pages 186-192 (January 2014) Combination of Diffusion-weighted Magnetic Resonance Imaging and Extended Prostate Biopsy Predicts Lobes Without Significant Cancer: Application in Patient Selection for Hemiablative Focal Therapy Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Hiroshi Tanaka, Jiro Kumagai, Soichiro Yoshida, Fumitaka Koga, Hitoshi Masuda, Satoru Kawakami, Yasuhisa Fujii, Kazunori Kihara European Urology Volume 65, Issue 1, Pages 186-192 (January 2014) DOI: 10.1016/j.eururo.2012.10.010 Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 1 Transverse, sagittal, and coronal projections of the 14-core prostate biopsy scheme: a combination of (A) the transperineal 8-core sampling using the fan technique and (B) the transrectal 6-core sampling from far-lateral peripheral zone. European Urology 2014 65, 186-192DOI: (10.1016/j.eururo.2012.10.010) Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 2 Conceptual schemes of the lobe category based on radical prostatectomy specimens: (A) lobe with no cancer, (B) lobe with indolent cancer, and (C) lobe with significant cancer. Small green area and large red area represent indolent and significant cancer foci, respectively. Small blue and orange circles represent neurovascular bundles. European Urology 2014 65, 186-192DOI: (10.1016/j.eururo.2012.10.010) Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 3 Flow diagram of the lobe category at pathologic examination of the radical prostatectomy specimens grouped according to the side-specific findings in diffusion-weighted imaging and 14-core biopsy. RP=radical prostatectomy; DWI=diffusion-weighted imaging; PBx=prostate biopsy; LNC=lobe with no cancer; LIC=lobe with indolent cancer; LSC=lobe with significant cancer. European Urology 2014 65, 186-192DOI: (10.1016/j.eururo.2012.10.010) Copyright © 2012 European Association of Urology Terms and Conditions